Charles Schwab Investment Management Inc. lifted its position in Xylem Inc. (NYSE:XYL - Free Report) by 0.4% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 1,345,768 shares of the industrial products company's stock after buying an additional 5,817 shares during the period. Charles Schwab Investment Management Inc. owned approximately 0.55% of Xylem worth $181,719,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors also recently bought and sold shares of the company. John G Ullman & Associates Inc. raised its stake in Xylem by 9.3% in the third quarter. John G Ullman & Associates Inc. now owns 2,580 shares of the industrial products company's stock valued at $348,000 after buying an additional 220 shares during the last quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. raised its position in shares of Xylem by 4.0% in the 3rd quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 881,697 shares of the industrial products company's stock valued at $119,056,000 after purchasing an additional 34,233 shares during the last quarter. King Luther Capital Management Corp boosted its stake in Xylem by 1.1% in the 3rd quarter. King Luther Capital Management Corp now owns 959,623 shares of the industrial products company's stock worth $129,578,000 after purchasing an additional 10,319 shares in the last quarter. Citizens Financial Group Inc. RI grew its position in Xylem by 9.2% during the 3rd quarter. Citizens Financial Group Inc. RI now owns 2,648 shares of the industrial products company's stock worth $358,000 after purchasing an additional 224 shares during the last quarter. Finally, Moors & Cabot Inc. increased its stake in Xylem by 1.3% during the 3rd quarter. Moors & Cabot Inc. now owns 7,936 shares of the industrial products company's stock valued at $1,072,000 after purchasing an additional 104 shares in the last quarter. Hedge funds and other institutional investors own 87.96% of the company's stock.
Analyst Ratings Changes
A number of equities research analysts have recently weighed in on the stock. TD Cowen dropped their price objective on shares of Xylem from $138.00 to $125.00 and set a "hold" rating on the stock in a report on Wednesday, November 6th. Stifel Nicolaus lifted their target price on Xylem from $170.00 to $172.00 and gave the stock a "buy" rating in a report on Wednesday, July 31st. Robert W. Baird reduced their price target on shares of Xylem from $175.00 to $154.00 and set an "outperform" rating for the company in a research report on Friday, November 1st. UBS Group initiated coverage on shares of Xylem in a report on Tuesday, August 13th. They issued a "buy" rating and a $165.00 price objective on the stock. Finally, Royal Bank of Canada reduced their target price on shares of Xylem from $163.00 to $162.00 and set an "outperform" rating for the company in a report on Friday, November 1st. Four equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. According to MarketBeat, Xylem currently has an average rating of "Moderate Buy" and a consensus target price of $149.64.
Read Our Latest Analysis on XYL
Xylem Price Performance
Shares of XYL traded up $1.51 during trading hours on Friday, hitting $126.87. 1,365,941 shares of the stock were exchanged, compared to its average volume of 1,580,471. Xylem Inc. has a 12-month low of $102.42 and a 12-month high of $146.08. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.42 and a current ratio of 1.96. The stock's 50-day moving average price is $130.14 and its two-hundred day moving average price is $134.27. The company has a market cap of $30.82 billion, a price-to-earnings ratio of 37.10, a price-to-earnings-growth ratio of 2.34 and a beta of 1.05.
Xylem (NYSE:XYL - Get Free Report) last posted its quarterly earnings results on Thursday, October 31st. The industrial products company reported $1.11 earnings per share for the quarter, hitting analysts' consensus estimates of $1.11. The firm had revenue of $2.10 billion for the quarter, compared to analyst estimates of $2.17 billion. Xylem had a net margin of 9.85% and a return on equity of 9.61%. Xylem's quarterly revenue was up .2% on a year-over-year basis. During the same period in the previous year, the business posted $0.99 earnings per share. Research analysts expect that Xylem Inc. will post 4.23 earnings per share for the current year.
Xylem Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 24th. Investors of record on Tuesday, November 26th will be issued a $0.36 dividend. This represents a $1.44 dividend on an annualized basis and a dividend yield of 1.14%. The ex-dividend date of this dividend is Tuesday, November 26th. Xylem's dividend payout ratio is currently 42.11%.
Xylem Profile
(
Free Report)
Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.
Read More
Before you consider Xylem, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.
While Xylem currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.